Literature DB >> 11112234

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

M M Samama1.   

Abstract

BACKGROUND: Little information is available concerning risk factors for venous thromboembolism (VTE) in nonhospitalized patients. PARTICIPANTS AND METHODS: An epidemiologic case-control study of deep vein thrombosis (DVT) risk factors was conducted in 1272 outpatients by general practitioners. The case population (636 patients presenting with DVT) was paired with the control population (636 patients presenting with influenzal or rhinopharyngeal syndrome) according to sex and age. Deep vein thrombosis was to be documented by at least 1 objective test. Risk factors were classified into "intrinsic" ("permanent") and "triggering" ("transient") factors and were evidenced using univariate analysis.
RESULTS: In the medical population, defined as patients who had not undergone surgery or application of a plaster cast to the lower extremities within the 3 weeks preceding inclusion (494 cases and 494 controls), intrinsic factors such as history of VTE, venous insufficiency, chronic heart failure, obesity, immobile standing position, history of more than 3 pregnancies, and triggering factors such as pregnancy, violent effort, or muscular trauma, deterioration of general condition, immobilization, long-distance travel, and infectious disease were significantly more frequent in the case patients than in the controls (odds ratio, >1; P<.05). In the overall population, additional risk factors were cancer, blood group A, plaster cast of the lower extremities, and surgery. In both populations, the number of risk factors per patient was greater in the case patients than in the controls.
CONCLUSION: Several risk factors for DVT were identified in medical outpatients presenting with DVT, and their comprehension may improve appropriateness and efficiency of the different methods available for thromboprophylaxis. Arch Intern Med. 2000;160:3415-3420.

Entities:  

Mesh:

Year:  2000        PMID: 11112234     DOI: 10.1001/archinte.160.22.3415

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  132 in total

1.  Maternal obesity and risk of neural tube defects.

Authors:  G Koren
Journal:  Can Fam Physician       Date:  2001-07       Impact factor: 3.275

2.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

3.  Invited commentary: Diet and risk of venous thromboembolism--a hard nut to crack.

Authors:  Pamela L Lutsey
Journal:  Am J Epidemiol       Date:  2011-12-15       Impact factor: 4.897

Review 4.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

Review 5.  Predicting the risk of recurrent venous thromboembolism (VTE).

Authors:  Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

6.  Incidence of Venous Thromboembolism Following Laparoscopic Surgery for Gastrointestinal Cancer: A Single-Center, Prospective Cohort Study.

Authors:  Yasue Kimura; Eiji Oki; Koji Ando; Hiroshi Saeki; Tetsuya Kusumoto; Yoshihiko Maehara
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

Review 7.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

Review 8.  Deep venous thrombosis prophylaxis in laparoscopy: an evidence-based review.

Authors:  William S Richardson; Keith Apelgren; Robert D Fanelli; David Earle
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

Review 9.  The epidemiology of venous thromboembolism in the community.

Authors:  John A Heit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

10.  Thromboembolic risk in the patient with heart failure.

Authors:  Liviu Klein; John B O'connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.